Characteristics of users and nonusers of plant stanol ester margarine in Finland: An approach to study functional foods

Journal of the American Dietetic Association

Volumn 101, Issue 11, 2001, Pages 1365-1368

  Anttolainen, Meri ^a   Luoto, Riitta ^b   Uutela, Antti ^a   Boice Jr , John D ^c,d   Blot, William J ^c,d   McLaughlin, Joseph K ^c,d   Puska, Pekka ^a,e  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b UNIVERSITY OF TAMPERE   (Finland)

^c INTERNATIONAL EPIDEMIOLOGY INSTITUTE   (United States)

^d VANDERBILT INGRAM CANCER CENTER   (United States)

^e WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; MARGARINE; SITOSTEROL DERIVATIVE; STANOL ESTER;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CARDIOVASCULAR DISEASE; COHORT ANALYSIS; DIET; DIET THERAPY; FEMALE; FINLAND; HEALTH BEHAVIOR; HUMAN; INCOME; MALE; QUESTIONNAIRE; SOCIOECONOMICS;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; ANTILIPEMIC AGENTS; CARDIOVASCULAR DISEASES; COHORT STUDIES; DIET SURVEYS; EDUCATIONAL STATUS; FEMALE; FINLAND; HEALTH BEHAVIOR; HUMAN; INCOME; MALE; MARGARINE; MIDDLE AGE; QUESTIONNAIRES; SITOSTEROLS; SUPPORT, NON-U.S. GOV'T;

EID: 0035513738     PISSN: 00028223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-8223(01)00327-3     Document Type: Article

References (21)

1. Ling WH, Jones PJH. Dietary phytosterols: a review of metabolism, benefits and side effects. Life Sciences. 1995;57:195-206.
2. JonesPJH, MacDougall DE, NtaniosF, Vanstone CA. Dietary phytosterols as cholesterol-lowering agents in humans. Can J Physiol Pharmacol. 1997;75:217-227.
3. Weststrate JA, Meijer GW. Plant sterol-enriched margarines and reduction of plasma total- and LDL-cholesterol concentrations in normocholesterolaemic and mildly hypercholesterolaemic subjects. Eur J Clin Nutr. 1998;52:334-343.
4. Jones PJ, Raeini-Sarjaz M, Ntanios FY, Vanstone CA, Feng JY, Parsons WE. Modulation of plasma lipid levels and cholesterol kinetics by phytosterol versus phytostanol esters. J Lipid Res. 2000; 41:697-705.
5. Law M. Plant sterol and stanol margarines and health. BMJ. 2000;320:861-864.
6. Miettinen TA, Puska P, Gylling H, Vanhanen H, Vartiainen E. Reduction of serum cholesterol with sitostanol-ester margarine in a mildly hypercholesterolemic population. N Engl J Med. 1995; 333:1308-1312.
7. Vanhanen HT, BlomqvistS, EhnholmC, Hyvönen M, Jauhiainen M, Torstila I, Miettinen TA. Serum cholesterol, cholesterol precursors, and plant sterols in hypercholesterolemic subjects with different apoE phenotypes during dietary sitostanol ester treatment. J Lipid Res. 1993;34:1535-1544.
8. Gylling H, Miettinen TA. Serum cholesterol and cholesterol and lipoprotein metabolism in hypercholesterolaemic NIDDM patients before and during sitostanol ester-margarine treatment. Diabetologia. 1994;37:773-780.
9. Gylling H, Siimes MA, Miettinen TA. Sitostanol ester margarine in dietary treatment of children with familial hypercholesterolemia. J Lipid Res. 1995;36:1807-1812.
10. Gylling H, Miettinen TA. Effects of inhibiting cholesterol absorption and synthesis on cholesterol and lipoprotein metabolism in hypercholesterolemic non-insulin-dependent diabetic men. J Lipid Res. 1996;37:1776-1785.
11. Gylling H, Radhakrishnan R, Miettinen TA. Reduction of serum cholesterol in postmenopausal women with previous myocardial infarction and cholesterol malabsorption induced by dietary sitostanol ester margarine: women and dietary sitostanol. Circulation. 1997;96:4226-4231.
12. Niinikoski H, Viikari J, Palmu T. Cholesterol-lowering effect and sensory properties of sitostanol ester margarine in normocholesterolemic adults. Scand J Nutr. 1997;41:9-12.
13. Hallikainen MA, Uusitupa MIJ. Effects of 2 low-fat stanol ester-containing margarines on serum cholesterol concentrations as part of a low-fat diet in hypercholesterolemic subjects. Am J Clin Nutr. 1999;69:403-410.
14. Gylling H, Miettinen TA. Cholesterol reduction by different plant stanol mixtures and with variable fat intake. Metabolism. 1999;48:575-580.
15. American Dietetic Association. Position of the American Dietetic Association: Functional foods. J Am Diet Assoc. 1999;99:1278-1285.
16. Vartiainen E, Jousilahti P, Alfthan G, Sundvall J, Pietinen P, Puska P. Cardiovascular risk factor changes in Finland, 1972-1997. Int J Epidemiol. 2000;29:49-56.
17. Helakorpi S, Uutela A, Prättälä R, Puska P. Health Behaviour among Finnish Adult Population, Spring 1998. Helsinki: Publications of the National Public Health Institute B10; 1998.
18. Prättälä R, Berg MA, Puska P. Diminishing or increasing contrasts? Social class variation in Finnish food consumption patterns, 1979-1990. Eur J Clin Nutr. 1992;46:279-287.
19. Suomen Sisätautilääkärien Yhdistys, Suomen Kardiologinen Seura, Suomen Verenpaineyhdistys, Kunnallislääkärit-yhdistys, Suomen Teollisuuslääketieteen Yhdistys, Suomen Sydäntautiliitto. Prevention of coronary heart disease in clinical practice [in Finnish]. Suom Lääkäril. 1996;51:783-802.
20. Vainio H, Mutanen M. Functional foods - blurring the distinction between food and medicine. Scand J Work Environ Health. 2000;26:178-180.
21. Jacobson MF, Silverglade B. Functional foods: health boon or quackery? Regulations are needed to govern their composition and advertising. BMJ. 1999;319:205-206.